KEVIN D-AMOUR
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
STEVEN R. ALTMAN, BRITTANY BRADRICK, ELIZABETH BUI, LIZ BUI, DONALD J. ELMER, MARK G. FOLETTA, HOWARD FOYT, PAUL HASTINGS, LUCIAN IANCOVICI, FRANKLIN P. JOHNSON, ORVILLE G. KOLTERMAN, ADAM KOPPEL, STEVE KRADJIAN, PAUL LAIKIND, HEATH LUKATCH, FRED A. MIDDLETON, SANDRA POOLE, ALLAN ROBIN, ALLAN ROBINS, ANNE SANDAN, MICHAEL SCOTT, IAN SMITH, STEVE WHITE, ASISH XAVIER, ASISH K. XAVIER, MICHAEL YANG, AMIR ZAMANI, MARK ZIMMERMAN
EXECUTIVE OFFICER
MATTHEW ANGEL, TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, SANDRA GURROLA, ANDREW JACKSON, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, DENNIS LANGER, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-03-09
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-04-06
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-03-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-11-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-08-08

